Position in ONC
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$167,562
-$7,056 QoQ
Shares Held
588
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#216
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Perspectives, Inc holds $866,211 across 15 Biotechnology names. ONC ranks #1 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
This page
|
588 | $167,562 | |
| 2 | ARGX |
Argenx SE
|
145 | $134,526 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
2,422 | $132,095 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,155 | $120,830 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
191 | $119,096 | |
| 6 | INCY |
Incyte Corp
|
1,000 | $113,360 | |
| 7 | GMAB |
Genmab A/S
|
1,333 | $36,617 | |
| 8 | MRNA |
Moderna, Inc.
|
230 | $16,106 |
All Filings in ONC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,562 | 588 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $174,618 | 588 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $178,640 | 588 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $200,331 | 588 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $142,337 | 588 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $160,035 | 588 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $108,609 | 588 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $195,099 | 869 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $123,980 | 869 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $135,902 | 869 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $156,732 | 869 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $156,307 | 869 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $154,942 | 869 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $187,295 | 869 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $191,127 | 869 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $117,158 | 869 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $140,647 | 869 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $163,893 | 869 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $200,488 | 740 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $196,746 | 542 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $401,875 | 1,171 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $1,171 | 407,602 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $302,574 | 1,171 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $259,801 | 907 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $170,878 | 907 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $111,660 | 907 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||